| Income statement (USD) | FY 2026 ended May 31, 2026 | FY 2025 ended May 31, 2025 | FY 2024 ended May 31, 2024 | FY 2023 ended May 31, 2023 | FY 2022 ended May 31, 2022 | FY 2021 ended May 31, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.45M | 5.31M | 5.42M | 5.34M | 18.87M | 7.20M |
| Cost of revenue | 4.09M | 4.81M | 4.80M | 4.89M | 15.89M | 6.83M |
| Gross profit | 362.0K | 498.0K | 611.0K | 446.0K | 2.98M | 366.3K |
| Research and development | 788.0K | 1.02M | 1.49M | 1.58M | 1.81M | 2.19M |
| Selling, general and admin | 4.89M | 4.61M | 5.49M | 6.08M | 5.70M | 5.67M |
| Operating expenses | 5.68M | 5.63M | 6.98M | 7.67M | 7.51M | 7.87M |
| Operating income | -5.32M | -5.14M | -6.37M | -7.22M | -4.53M | -7.50M |
| EBITDA | -5.24M | -5.05M | -6.29M | -7.14M | -4.20M | -7.39M |
| Interest expense | 367 | |||||
| Income before tax | -3.75M | -4.97M | -5.94M | -7.09M | -4.51M | -7.43M |
| Income tax | 23.0K | 1.0K | 42.0K | 51.0K | 24.0K | 13.1K |
| Net income | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M | -7.45M |
| EPS | -1.30 | -2.16 | -2.84 | -0.50 | -0.36 | -0.62 |
| EPS (diluted) | -1.30 | -2.16 | -2.84 | -0.50 | -0.36 | -0.62 |
| Diluted shares | 2.91M | 2.30M | 2.10M | 14.15M | 12.67M | 11.93M |
From Biomerica Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.